In a move that signals a completely new approach in its industry, pharmaceutical giant GlaxoSmithKline (GSK) has announced that it will participate in a patent
Professor Shamnad Basheer (National University of Juridical Sciences, Kolkata) is an IP Osgoode Research Affiliate and is also the founder of SpicyIP, a leading blog
Industry responses to the European Commission (EC) preliminary report on pharmaceutical competition (see the IPilogue blog of Dec. 15, 2008) are becoming available, and criticism
A few weeks ago, the Honourable Paul Michel sat down for an interview with Professor Doug Lichtman from UCLA School of Law. Judge Michel is
The global economic downturn continues to make its impact. A few months ago, I mentioned the possibility that patents might be used to leverage credit,
The balance between private and public interests is usually the centre of most intellectual property policy debates, but this can be said to be especially
